GGrantIndex
Sort

89,613 grants matching depression

Investigating Correlates and Therapeutics of Fatigue

$3,655,006
Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2022 · NR

The Pathophysiology and Treatment of Children with Severe Irritability ZIA MH002786-17

$3,643,198
Ellen Leibenluft · National Institute Of Mental Health · ZIA · FY2018 · MH

A Multi-Center Group to Study Acute Liver Failure in Children

$3,638,432
Robert H Squires · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · DK

Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity

$3,636,473
Arjun Deb · University Of California Los Angeles · R01 · FY2021 · DK

Border Biomedical Research Center

$3,634,786
Robert Kirken · University Of Texas El Paso · U54 · FY2023 · MD

Multimorbidity Combinations and Dementia Onset Among Race/Ethnic Older Adults

$3,634,165
Ana Roman Quinones · Oregon Health & Science University · RF1 · FY2019 · AG

Using AI to unpack the bi-directional association between adolescent social media exposure and mental health and well being

$3,633,977
Michele Ybarra · Center For Innovative Public Health Research · RF1 · FY2025 · MH

BIOMEDICAL IMAGING RESEARCH NETWORK

$3,631,457
Mark H Ellisman · University Of California, San Diego · U24 · FY2007 · RR

Clinical Evaluation of PET Radiotracers

$3,612,538
Robert Innis · National Institute Of Mental Health · ZIA · FY2015 · MH

BIOMEDICAL IMAGING RESEARCH NETWORK

$3,610,828
Mark H Ellisman · University Of California, San Diego · U24 · FY2006 · RR

East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium

$3,607,664
Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2022 · AI

Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect

$3,606,404
Carlos Zarate · National Institute Of Mental Health · ZIA · FY2015 · MH

Development of (R,R)-dehydronorketamine for treatment resistant depression

$3,601,077
Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR

Development of (R,R)-dehydronorketamine for treatment resistant depression

$3,594,882
Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR

Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders

$3,588,880
Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · UG3 · FY2019 · DA

EPIDEMIOLOGY-- NATIONAL COMORBIDITY SURVEY REPLICATION

$3,568,662
Harvard University (Medical School) · U01 · FY2001 · MH

WOMENS INTERAGENCY HIV STUDY (WIHS)

$3,568,374
University Of Southern California · U01 · FY2002 · HD

Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdose

$3,564,333
Marco Pravetoni · University Of Washington · UH3 · FY2023 · DA

MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS

$3,558,712
Neelum T Aggarwal · Rush University Medical Center · R01 · FY2021 · AG

Early Markers of Alzheimer Disease

$3,543,738
Susan Resnick · National Institute On Aging · ZIA · FY2017 · AG

Procurement and Characterization of Postmortem Brain Tissue

$3,540,601
Barbara Lipska · National Institute Of Mental Health · ZIC · FY2017 · MH

Optogenetic dissection of cellular and circuit mechanisms of network dysfunction and amyloid deposition in mouse models of Alzheimer's disease in vivo

$3,540,000
Jorge J Palop · J. David Gladstone Institutes · RF1 · FY2018 · AG

Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage

$3,534,431
Katharina Maria Busl · University Of Florida · U01 · FY2024 · NS

BIOMEDICAL IMAGING RESEARCH NETWORK

$3,533,242
University Of California San Diego · U24 · FY2005 · RR

PET Radiopharmaceutical Sciences

$3,529,636
Victor W Pike · National Institute Of Mental Health · Z01 · FY2007 · MH